Susan Hasty, Publisher
Table of Contents . . . June 14th, 1999Non-Subscriber - Summaries Only
Conference Coverage (ASCO) - E2F-1 Gene Therapy Is A Promising Anti-Cancer Strategy
Conference Coverage (ASCO) - Combination Therapy Well Tolerated in Ovarian Cancer Patients
Animal Models - System Permits Study of Rh Function and Structure
Epidemiology - For 15 years, Research Group Has Been at Forefront of AIDS
Genetics - Cancer Role of Mutated Gene Revealed
Genetics - Protein Abnormality Associated with AD Found
Huntington's Disease - Inhibiting Key Enzyme Slows Disease Progression in Mice
Industry News (Joint Venture) - Distribution and Marketing Agreement Entered in Japan
Prostate Cancer (Treatment) - Preliminary Gene Therapy Success in Fighting Prostate Cancer
Risk Factors - Glutathione S-Transferase Genes and Neurological Disease
Tuberculosis (Prevention) - Lost Genes May Be Causing TB Vaccine's Failure
Allogeneic Bone Marrow Transplant - "Modulation of Anti-Tumor Responses by Transforming Growth Factor (beta) in a Murine Allogeneic Bone Marrow Transplant Model."
Cancer Vaccines - "Systemic Immunotherapy of Advanced Prostate Cancer (CaP): Preliminary Results of a Phase I Clinical Trial Using Recombinant Vaccina Virus Encoding Human MUC-1 and Interleukin-2 (ILD
Vaccine Development (HIV) - "Enhancement of Mucosal Immune Responses to HIV Gp160."